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Background: The net clinical beneﬁt of high-energy nutritional supplements (HENSDs) consumption is
lower than expected.
Objectives: To investigate the extent to which consumption of oral HENSD in the fasted state reduces
energy intake in slim females during consecutive breakfast and lunch, and whether this relates to
changes in appetite and metabolic appetite regulators.
Design: Twenty three females of 24.4 ± 2.8 years with BMI of 18.2 ± 0.8 kg/m2 consumed HENSD (2.5 MJ)
or PLACEBO (0.4 MJ) in fasted state in a single blind randomized cross-over study. Appetite and metabolic
rate measurements and blood collection were conducted prior to and during 240 min after the intake of
the supplements. Energy intake was recorded during ad libitum buffet breakfast and lunch served 60 min
and 240 min post supplementation respectively.
Results: Energy intake during breakfast was signiﬁcantly (P < 0.01) lower in the HENSD trial but the net
cumulative effect on energy intake was 1.07 ± 0.34 MJ higher in the HENSD compared to PLACEBO.
Plasma concentration of CCK and PYY and insulin and were signiﬁcantly (P < 0.05) higher in the HENSD
trial while appetite measures were not signiﬁcantly different between HENSD and PLACEBO trials.
Correlations for the within participant relations between the responses of plasma hormones and appetite
scores were signiﬁcant (P < 0.05) for PYY and insulin but not CCK. The energy expended above resting
metabolic rate was signiﬁcantly (P < 0.05) higher in the HENDS trial but relative increase in energy
expenditure was not signiﬁcantly different between the two trials.
Conclusion: Oral high-energy nutritional supplements have a partial and relatively short lived sup-
pressive action on energy intake and can be expected to increase net energy intake by approximately half
the energy value of the supplement consumed.
© 2015 Published by Elsevier Ltd.100
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1101. Introduction
Systematic reviews and meta-analyses consistently suggest that
oral, ready to drink high energy liquid supplements (HENSD)
improve body weight and energy and nutritional intake, and thus
may have various clinical and functional beneﬁts in patients with
an increased risk of becoming malnourished (Cawood, Elia, &
Stratton, 2012; Stratton & Elia, 2010; Stratton, Hebuterne, & Elia,upplement drinks; PYY, Pep-
onse vs. time curves.
alkova).
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S., et al., Response of appetit
ttp://dx.doi.org/10.1016/j.app2013). HENSD typically contain a mixture of macro and micro-
nutrients, providing between 6$3 kJ/ml to 10$1 kJ/ml per typical
serving of 125e220 ml (Stratton & Elia, 2010). Although HENSD
should increase daily energy intake by an average of 1569 kJ/d, their
net beneﬁt is lower than anticipated (Milne, Avenell, & Potter,
2005; Poustie, Russell, Watling, Ashby, & Smyth, 2006), implying
that HENSD consumption partially displaces food and energy
intake during habitual meals. As another determinant of energy
balance, energy expended during physical activity, may also play an
important role. Indeed, a study investigating the impact of oral
nutritional supplementation in depleted ambulatory patients with
chronic obstructive pulmonary disease suggests that absence of
body weight gain during three months of supplementation may be116
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Table 1
Energy, carbohydrate (CHO), fat and protein provided by HENSD and PLACEBO
drinks.
HENSD PLACEBO
Energy (MJ) 2.49 0.38
CHO (g) 68.8 g 11.3 g
Fat (g) 30.4 g 1.3 g
Protein (g) 11.9 g 9 g
Energy from CHO (%) 46 48
Energy from Fat (%) 46 13
Energy from Protein (%) 8 39
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APPET2608_proof ■ 26 June 2015 ■ 2/8explained by enhanced energy expenditure via physical activity
(Goris, Vermeeren, Wouters, Schols, & Westerterp, 2003).
So far, the mechanisms mediating compensation of habitual
energy intake in relation to malnutrition treatment have been
investigated primarily in tube feeding studies and only considered
the role of metabolic and hormonal appetite regulators (Stratton &
Elia, 1999; Stratton, Stubbs,& Elia, 2008). Oral intake compensation
for energy provided by 3 days of bolus tube feeding has been re-
ported to be equivalent to 40% of the bolus feed energy content,
with plasma concentration of ghrelin, leptin, insulin, and glucose
being modiﬁed in the direction expected to reduce hunger and
increase satiety (Stratton et al., 2008). It is important to note that
tube feeding delivers nutrients directly into the stomach and thus
bypasses the sensory aspects of oral consumption and the cephalic
phase response (Stratton & Elia, 1999; Stratton et al., 2008). Thus,
the interaction between appetite, food intake, and the wider
spectrum of hormonal appetite and satiety regulators following
oral supplementation remains to be investigated.
Appetite and energy intake following food or supplement con-
sumption can also relate to their impact on gastric emptying and
diet induced thermogenesis as reduced hunger and enhanced
satiety were reported to be linked with delayed gastric emptying
(Wang et al., 2008) and with higher diet induced thermogenesis
(Crovetti, Porrini, Santangelo, & Testolin, 1998; Mansour et al.,
2012). Therefore, the aim of this study was to investigate the
level of energy intake compensation in lean adult women following
HENSD consumption and ﬁnd out how it relates to responses of a
range of hormonal and metabolic appetite regulators as well as a
measure of gastric emptying and diet induced thermogenesis.
2. Material and methods
2.1. Participants
Eligible participants of this study were slim (BMI < 20 kg/m2),
healthy, young women recruited by means of advertisement and
word of mouth in the campus of the University of Glasgow and in
other public places. Participants were non-smokers, with stable
weight for one month prior to the study, not pregnant, had regular
menstrual cycle, and were not on any medication, nutritional
supplement or following a special diet. Before enrolling in the
study, participants underwent a detailed health screen regarding
participant's health to exclude chronic illness, eating disorders and
past history of gastrointestinal operations which could interfere
with the results of the study. All participants gave written informed
consent. The study was approved by College of Medical, Veterinary
and Life Sciences Ethics Committee of Glasgow University.
2.2. Study design
This study used a single blind crossover design with two
randomly sequenced experimental trials, separated by four weeks.
On themorning of the experiment trial, participants reported to the
metabolic investigation room between 0800 and 0900 after 12 h
fast. Height (Seca, Leicester, UK) body mass and body fat (TBF-300,
TANITA, Cranlea, UK), and resting metabolic rate (RMR) were
measured. A venous cannula was then inserted and, after an in-
terval of 10 min, baseline blood sample was obtained. Subse-
quently, an appetite questionnaire was completed. Within 10 min,
participants were then asked to consume 240 ml of either a HENSD
(Scandishake, Chocolate, Nutricia) prepared with full fat milk
(HENSD trial), supplying 2.5MJ, or a low calorie drinkmade upwith
skimmed milk, cocoa and artiﬁcial sweeteners (PLACEBO trial),
supplying 0.4 MJ (Table 1). Participants were blinded of the preload
drink and they were not told which drink they would consume andPlease cite this article in press as: Fatima, S., et al., Response of appetit
nutritional supplements, Appetite (2015), http://dx.doi.org/10.1016/j.appthe order in which drinks were provided was randomly allocated.
HENSD and PLACEBO drinks had the same colour, volume, ﬂavour
and texture and were not distinguishable, as reported in an inde-
pendent pilot trial. Following supplement intake, 1000 mg of
paracetamol with 100 ml of water were given to participants to
measure a proxy of gastric emptying (Clements, Heading, Nimmo,
& Prescott, 1978). Participants completed further appetite ques-
tionnaires and blood samples were collected at 30 and 60 min post
supplement e whilst metabolic ratewas measured everyminute for
the duration of 20 min after each blood sample. One hour after
supplement consumption, an ad libitum buffet style breakfast was
served. Appetite questionnaires and blood samples were collected
at 120, 150, 180, 210, and 240 min. An ad libitum buffet lunch was
presented 240 min after the baseline measurements (see Table 2).
2.3. Ad libitum buffet meals
Ad libitum buffet meals consisted of a variety of standardised
foods with total energy about three times what participants were
expected to consume. Theywere served in the same setting, serving
the same type of food in the same coloured dishes schedulingmeals
at the same time, and in the same table in order to avoid any bias in
eating behaviour. The participants were given 30 min to consume
their meal and were advised to eat according to their appetite until
satisﬁed and comfortably full. Breakfast comprised of a variety of
breakfast cereals, milk (semi-skimmed, skimmed and whole
cream), croissants, jam, butter, banana and apples, apple and or-
ange juice. Lunch comprised of two ﬁlled white bread sandwiches,
two ﬁlled whole meal bread sandwiches, mixed leaf salad, yoghurt,
apple, banana, grapes, and apple or orange juice. The food was cut
into smaller pieces to eliminate portion related cues. All food
offered and remaining after the intake was weighed by the
researcher using an electronic kitchen scale (Salter Housewares
Ltd., Tonbridge, U.K.). Water was available throughout the trial.
Participants were given 30 min to consume their meal and were
advised to eat according to their appetite until satisﬁed and
comfortably full. The researchers were not present when the par-
ticipants ate their meals to avoid any potential effect of the
researcher on feeding behaviour. The participants were blinded to
the actual purpose of buffet meals i.e. measurement of food intake.
3. Measurement of food and energy intake
The macronutrient and energy intake was calculated by dietary
software Windiets 2005 (The Robert Gordon University, Aberdeen,
Scotland, UK). The calculations on energy andmacronutrient intake
were independently conducted by two researchers and mean
values of two calculations were used.
3.1. Appetite measurements
Participants were asked to mark their feeling of hunger, satiety,
fullness, prospective food consumption and desire to eat on Visuale and potential appetite regulators following intake of high energy
et.2015.06.010
Table 2
Energy, carbohydrate (CHO), protein and fat intake in HENSD and PLACEBO trials. Values are presented as Mean ± SE, (n ¼ 23).
HENSD PLACEBO
Supplement Energy (MJ) 2.49 0.38
Breakfast Energy (MJ) 1.92 ± 0.17 2.89 ± 0.23**
CHO (g) 80 ± 8 113 ± 1*
Protein (g) 11 ± 1 16 ± 1*
Fat (g) 12 ± 1 21 ± 2**
Supplement þ Breakfast Energy (MJ) 4.41 ± 0.17 3.27 ± 0.23**
CHO (g) 149 ± 7.65 125 ± 9.70*
Protein (g) 24 ± 1 25 ± 1
Fat (g) 42 ± 1 23 ± 2**
Lunch Energy (MJ) 2.16 ± 0.16 2.27 ± 0.20
CHO (g) 69 ± 5 72 ± 7
Protein (g) 22 ± 2 24 ± 2
Fat (g) 18 ± 1.6 18 ± 1.9
Breakfast þ Lunch Energy (MJ) 4.09 ± 0.26 5.16 ± 0.32**
CHO (g) 150 ± 11 186 ± 13**
Protein (g) 33 ± 3 40 ± 3*
Fat (g) 30 ± 2 40 ± 3**
Breakfast þ Lunch þ Supplement Energy (MJ) 6.58 ± 0.26 5.54 ± 0.32**
CHO (g) 219 ± 11 197 ± 13
Protein (g) 45 ± 3 50 ± 3
Fat (g) 60 ± 2 41 ± 3**
Signiﬁcantly different (*P < 0.05, **P < 0.01) from HENSD trial.
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APPET2608_proof ■ 26 June 2015 ■ 3/8Analogue Scale (VAS) line of 100 mm (A Flint, Raben, Blundell, &
Astrup, 2000) by placing a vertical mark on the horizontal line at
a point corresponding to their feelings at that time. The lines were
anchored by negative feeling words (I am not hungry at all) on the
left and by positive feeling words (never being hungrier) on the
right. Quantiﬁcation of the measurement was made by measuring
distance from the left end of the line to the participant's mark.
3.2. Measurements of metabolic rate
Participants were rested in the supine position for 10min before
fasting expired air samples were collected using a ventilated hood
system (Oxycon Pro, Jaeger GmbH, Hoechberg, Germany). The rate
of oxygen consumption ( _VO2) and rate of carbon dioxide produc-
tion ( _VCO2) were recorded every minute for the duration of 20min.
These values were then used to calculate rate of energy expenditure
by using indirect calorimetry equations described elsewhere (Frayn
& Macdonald, 1997). Diet induced thermogenesis for the pre-
breakfast period (0e60 min) was calculated by multiplying the
duration of this period by the difference between the mean values
of the metabolic rate measured for 60 min after supplement con-
sumption and the metabolic rate measured at rest. Similarly, diet
induced thermogenesis for the pre-lunch period (60e240min) was
calculated by multiplying the duration of this period and the dif-
ference between the mean values of the metabolic rate measured
for 180 min after breakfast and mean value of the metabolic rate
measured at rest. For the validation of the accuracy of Oxycon Pro
system, an alcohol-burning test (Miodownik, Melendez, Carlon, &
Burda, 1998) was included in the Standard Operating Procedure
of the system and was conducted weekly with CV of 1.9%. In
addition, prior to data collection, the reliability of Oxycon Pro
systemwas determined by comparing resting _VO2 and _VCO2 values
obtained for 20 min in nine healthy volunteers with normal body
weight in the fasted state on two occasions, with an interval of
seven-eight days. During the 2 days before the ﬁrst measurement
participants weighted and recorded all foods consumed and were
asked to replicate this food intake during the 2 days preceding the
second measurement. In addition, participants refrained from ex-
ercise and alcohol intake for 2 days prior each measurement. Mean
_VO2 and _VCO2 values were 0.27 (SD 0.02) and 0.22 (SD 0.02) litres/
min for the ﬁrst measurements and 0.27 (SD 0.03) and 0.22 (SDPlease cite this article in press as: Fatima, S., et al., Response of appetit
nutritional supplements, Appetite (2015), http://dx.doi.org/10.1016/j.app0.03) litres/min for the second measurement, respectively. The
mean difference between measurements was 0.6 (SD 6.1) % for _VO2
and 0.7 (SD 4.6) % for _VCO2 and the Pearson correlation coefﬁcients
between measurements were 0.91 (P < 0.0005) for _VO2 and 0.94
(P < 0.0005) for _VCO2.
3.3. Metabolic appetite regulators
Venous blood samples were collected into ethylenediamine
tetra-acetic acid (EDTA) Vacutainer tube (BD Vacutainer Systems,
Plymouth, UK). Blood samples used for the analysis of insulin,
glucose and for paracetamol concentrations were centrifuged at
4 C, 3000 rpm for 15 min. After centrifugation the plasma super-
natant was aspirated and frozen at80 C until analysed. The blood
sample used for the determination of CCK and PYY was aliquoted
into eppendorf tubes containing Aprotinin (0.6 TIU activity per ml,
SigmaeAldrich, UK) and then centrifuged at 14000 rpm for 4 min.
Subsequently 300 mL of plasma was aliquoted into eppendorf tubes
and kept until analysis at 80 C. Plasma glucose was measured by
enzymatic colorimetric method (Roche Diagnostics, Mannheim,
Germany). Commercially available ELISA kits were used to measure
concentration of plasma insulin (Mercodia, Uppsala, Sweden), PYY
(Merck, Millipore, Bioscience Division, UK), and CCK (Phoenix,
Pharmaceuticals, Inc., Burlingame, CA, USA). For assessment of
gastric emptying, plasma paracetamol concentrationwasmeasured
using the Acetaminophen Assay kits (Cambridge Life Sciences,
Cambridge, U.K.). All samples for each participant were analysed in
a single analyser run to minimise inter-assay variation. Coefﬁcients
of variation were <3% for all non-ELISA assays, <4% for the insulin
ELISA and <8% and <7% for the PYY, and CCK respectively.
4. Statistical analysis
Two-way repeated measures ANOVA followed by post hoc
Tukey tests was used to compare changes over time and between
two trials. The total areas under the variable versus time curve
(AUC), calculated using the trapezium rule, and the incremental
AUC, calculated as the increment in AUC over baseline concentra-
tions, were also used for the comparison of summary of the pre-
breakfast (0e60 min) and pre-lunch (0e240 min) responses.
Paired t-tests were used to compare summary data, fasting values,e and potential appetite regulators following intake of high energy
et.2015.06.010
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APPET2608_proof ■ 26 June 2015 ■ 4/8and energy intakes between the two trials. To assess the strength of
within-subject relation between changes in appetite scores and
changes in hormone and glucose concentrations, regression slopes
and R2 values for the regression of appetite score on hormone and
glucose concentrations for the corresponding time points were
calculated (Lemmens, Martens, Kester, & Westerterp-Plantenga,
2011). Student's one sample t-tests were used to test whether the
means of the regression slopes were different from zero. Statistical
analyses were performed using Statistica (version 6.0; StatSoft, Inc,
Tulsa,OK) andMinitab (version 13.1; Minitab, Inc., State College,PA).
5. Results
Twenty-three healthy women with a mean (±SD) age of
24.4 ± 2.8 years (range: 18e35 years), body mass index (BMI) of
18.6 ± 0.9 kg/m2 (range: 17e20 kg/m2) and body fat mass of
9.1 ± 3.3 kg were recruited in this study. One participant dropped
out and one participant developed vomiting on the day of trial thus
21 participants completed the study.
5.1. Energy intake
Data on energy and macronutrient intake for HENSD and PLA-
CEBO trials are presented in Fig. 1 and Table. Ad libitum energy
intake during breakfast was signiﬁcantly (P < 0.05) lower in HENSD
compared with PLACEBO trial but there was no signiﬁcant differ-
ence between the two trials in the energy intake during lunch. For
HENSD the suppression of energy intake during breakfast was
equivalent to 57 ± 14% of energy provided by the supplement. Thus
the total energy intake, calculated as a sum of energy intake during
breakfast and lunch, and energy provided by supplement was byFig. 1. Energy intake from supplements, breakfast and lunch in HENSD and PLACEBO
trials. Values are presented as mean ± SE, n ¼ 21. *Signiﬁcantly (P ¼ 0.001) different
from energy intake during breakfast in PLACEBO trial; **Signiﬁcantly (P ¼ 0.006)
different from total energy intake in PLACEBO trial.
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nutritional supplements, Appetite (2015), http://dx.doi.org/10.1016/j.app1.07 ± 0.34 MJ higher (P ¼ 0.006) in HENSD than the PLACEBO trial.
Since the predicted daily energy requirement of our participants
consisted of 6.72 ± 0.27 MJ, HENSD supplementation increased
energy intake above the predicted daily energy requirement by
16.6 ± 5.3% with combined consumption of the supplement and
breakfast providing 67 ± 5% and 59 ± 4% and combined con-
sumption of the supplement, breakfast and lunch achieving
102 ± 8% and 83 ± 6% of daily energy requirement in HENSD and
PLACEBP trials, respectively.
5.2. Appetite responses
Responses of appetite measures during HENSD and PLACEBO
trials are presented in Fig. 2. Analyses by two way ANOVA showed
that all appetite measures were not signiﬁcantly different between
HENSD and PLACEBO trials (P > 0.05, trial effect). However, during
pre-breakfast period (0e60 min) summary response (calculated as
AUC) of hunger (P ¼ 0.03) and desire to eat (P ¼ 0.007) were
signiﬁcantly lower, and satiety (P ¼ 0.03) and fullness (P ¼ 0.006)
were signiﬁcantly higher in HENSD than PLACEBO trial. During the
pre-lunch period (60e240 min) summary response of hunger,
desire to eat, fullness, and satiety were not signiﬁcantly different
between HENSD and PLACEBO trails.
5.3. Metabolic rate and diet induced thermogenesis
Metabolic rate measured before and after supplement and
breakfast intake is illustrated in Fig. 3. Restingmetabolic rate (RMR)
was not signiﬁcantly (P < 0.05) different between HENSD and
PLACEBO trials (HENSD, 3.1 ± 0.1 kJ/min; PLACEBO, 3.21 ± 0.1 kJ/
min). In both trials, measured RMR expressed for 24 h (HENSD,
4.59 ± 0.12 MJ/day; PLACEBO 4.74 ± 0.15 MJ/day) was signiﬁcantly
lower (P < 0.001) than RMR calculated using Harris Benedict
equation (Frankenﬁeld, Muth, & Rowe, 1998) (HENSD,
5.48 ± 0.59 MJ/day; PLACEBO 5.48 ± 0.60 MJ/day). Differences be-
tween calculated RMR and measured RMR consisted of
0.90 ± 0.14 MJ/day and 0.74 ± 0.13 MJ/day in HENSD and PLACEBO
trials, respectively and calculated-RMR was within 12e13% of the
measured RMR in the participants of this study.
Analysis by repeated-measures ANOVA showed that the post-
prandial response of metabolic rate was signiﬁcantly higher in the
HENSD trial than in the PLACEBO trial (P < 0.05, trial effect). The
amount of energy expended above resting metabolic rate (diet
induced thermogenesis) during both pre-breakfast (P ¼ 0.04) and
pre-lunch (P ¼ 0.01) was signiﬁcantly higher in HENSD than PLA-
CEBO with the difference in energy expended above the metabolic
rate during the whole duration of the experimental trials being
0.124 ± 0.03 MJ (Table 3). After the supplement intake (0e60 min),
the relative increase in energy expenditure (expressed as per-
centage of energy provided by the supplement) was not signiﬁ-
cantly different between two trials (HENSD, 1.1 ± 0.2%; PLACEBO,
2.7 ± 0.3%). Additionally, there was no signiﬁcant difference in the
relative increase in energy expenditure between trials following
combined intake of the supplement and breakfast (0e240 min)
(HENSD, 3.9 ± 0.5%; PLACEBO, 3.7 ± 0.6%).
5.4. Metabolic and hormonal responses
Responses of metabolic and hormonal appetite regulators are
presented in Fig. 4. Analysis by repeated-measures ANOVA showed
that plasma concentration glucose, insulin, CCK and PYY was
signiﬁcantly higher in the HENSD trial than in the PLACEBO trial
(P < 0.05, trial effect). Summary responses of metabolic and hor-
monal appetite regulators, calculated as time-averaged AUC for
pre-lunch and pre-breakfast periods, are presented in Table 4.e and potential appetite regulators following intake of high energy
et.2015.06.010
Fig. 2. Measures of hunger, satiety, fullness, and desire to eat in the fasted state (0 min), during pre-breakfast period (0e60 min) and pre-lunch periods (60e240 min) in HENSD and
PLACEBO trials. Analysis by repeated-measures ANOVA showed that for all appetite measures differences were not signiﬁcantly different between HENSD and PLACEBO trials
(P < 0.05, trial effect). The supplements were consumed immediately after the fasting measurements. Values are presented as mean ± SE, n ¼ 21.
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glucose was signiﬁcantly (P ¼ 0.0001) higher in HENSD than PLA-
CEBO trial, whilst during the pre-lunch period there was no sig-
niﬁcant difference (P ¼ 0.06) between trials for this measure.Fig. 3. Metabolic rate measured in the fasted state (0 min), during pre-breakfast period
(0e60 min) and pre-lunch (60e240 min) periods in HENSD and PLACEBO trials.
Analysis by repeated-measures ANOVA showed that metabolic rate was signiﬁcantly
higher in HENSD than in PLACEBO trials (P < 0.05, trial effect). The supplements were
consumed immediately after the fasting measurements. Values are presented as
mean ± SE, n ¼ 21.
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nutritional supplements, Appetite (2015), http://dx.doi.org/10.1016/j.appDuring the pre-breakfast period, time-averaged AUC for plasma
insulin (P ¼ 0.006), CCK (P ¼ 0.04) and PYY (P ¼ 0.006) were
signiﬁcantly higher in HENSD than PLACEBO trial. Time-averaged
AUC for CCK (P ¼ 0.001) and PYY (P ¼ 0.006) were also signiﬁ-
cantly higher in the HENSD than PLACEBO trial during the pre-
lunch period, Mean concentration of plasma paracetamol, a proxy
measure of gastric emptying, during the pre-breakfast period
(HENSD, 14 ± 4 ml/ml; PLACEBO, 26 ± 2 ml/ml) was signiﬁcantly
(P¼ 0.01) lower in HENSD trial than in PLACEBO trial, whilst during
the pre-lunch period (HENSD, 68 ± 4 ml/ml; PLACEBO, 73 ± 5 ml/ml,
P ¼ 0.30), no signiﬁcant difference was found between trials.114
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1195.5. Regression of appetite measures on hormone and glucose
responses
Regression slopes, 95% CIs and R2 values for the regression of
appetite scores on hormone and glucose concentrations for theTable 3
Diet induced thermogenesis (kJ) after supplement (pre-breakfast) and breakfast
(pre-lunch) consumption, and during the entire duration (0e240min) of the HENSD
and PLACEBO trials. Values are presented as Mean ± SE, (n ¼ 21).
HENSD PLACEBO
Pre-breakfast 27.5 ± 5.2 10.7 ± 6.3*
Pre-lunch 143.0 ± 19.1 95.9 ± 16.1**
Over 240 min 296.6 ± 37.8 171.8 ± 40.0**
Signiﬁcantly different (*P < 0.05, **P < 0.001) from HENSD trial.
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Fig. 4. Plasma concentration of glucose, insulin, cholecystokinin (CCK), peptide YY (PYY) in the fasted state (0 min), during pre-breakfast period (0e60 min) and pre-lunch periods
(60e240 min) in HENSD and PLACEBO trials. Analysis by repeated-measures ANOVA showed that concentration glucose, insulin, CCK and PYY was signiﬁcantly higher in the HENSD
trial than in the PLACEBO trial (P < 0.05, trial effect). Values are presented as mean ± SE, n ¼ 9.
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APPET2608_proof ■ 26 June 2015 ■ 6/8corresponding time points are presented in Table 5. Relations be-
tween the responses of PYY and responses of appetite scores
showed signiﬁcant correlation (Satiety: R2 ¼ 0.3 ± 0.08, P < 0.01;
Fullness: R2 ¼ 0.3 ± 0.07, P < 0.01; Hunger, R2 ¼ 0.3 ± 0.07, P < 0.05;
Desire to eat, R2¼ 0.3 ± 0.08, P < 0.01). Correlations for the relations
between responses of insulin and responses of appetite scores were
also signiﬁcant (Satiety: R2 ¼ 0.4 ± 0.08, P < 0.001; Fullness:Table 4
Time-averaged AUC for the responses of glucose, insulin, peptide YY (PYY), chole-
cystokinin (CCK) during pre-breakfast, pre-lunch period and during the entire
period (240 min) of the HENSD and PLACEBO trials. Values are presented as
Mean ± SE, (n ¼ 9).
HENSD PLACEBO
Glucose (mmol/L)
Pre-breakfast 6.37 ± 0.25 5.51 ± 0.18**
Pre-lunch 6.76 ± 0.21 6.09 ± 0.29
Over 240 min 6.66 ± 0.17 5.95 ± 0.24*
Insulin (mU/L)
Pre-breakfast 25.55 ± 6.00 7.94 ± 1.43**
Pre-lunch 33.80 ± 6.54 32.73 ± 5.69
Over 240 min 30.84 ± 5.74 26.41 ± 4.54*
PYY (pg/ml)
Pre-breakfast 112 ± 10 76 ± 9**
Pre-lunch 136 ± 8 101 ± 11**
Over 240 min 130 ± 8 95 ± 10**
CCK (ng/ml)
Pre-breakfast 2.2 ± 0.19 2.0 ± 0.22*
Pre-lunch 2.43 ± 0.17 2.06 ± 0.13**
Over 240 min 2.39 ± 0.17 2.05 ± 0.15**
Paracetamol (ml/ml)
Pre-breakfast 14 ± 4 26 ± 2*
Pre-lunch 68 ± 4 73 ± 5
Over 240 min 55 ± 4 61 ± 4
Signiﬁcantly different (*P < 0.05, **P < 0.001) from HENSD trial.
Please cite this article in press as: Fatima, S., et al., Response of appetit
nutritional supplements, Appetite (2015), http://dx.doi.org/10.1016/j.appR2 ¼ 0.4 ± 0.08, P < 0.001; Hunger, R2 ¼ 0.4 ± 0.06, P < 0.01; Desire
to eat, R2 ¼ 0.5 ± 0.09, P < 0.001), while responses of glucose
showed signiﬁcant correlation only with responses of Fullness
(R2 ¼ 0.2 ± 0.05, P < 0.05) and Desire to Eat (R2 ¼ 0.2 ± 0.07,
P < 0.01). Correlations for the relations between responses of CCK
and responses of appetite scores were not signiﬁcant.106
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108
109
1106. Discussion
The aim of this study was to provide insight into the appetite,
metabolic, hormonal and gastric emptying responses to HENSDTable 5
Means (±SE), 95 CIs for the means of the observed slopes and R2 values for within-
subject relations between appetite scores and hormone and glucose concentrations.
Slope 95% CI R2
Satiety vs PYY 0.5 ± 0.1* 0.3, 0.8 0.3 ± 0.08
Fullness vs PYY 0.5 ± 0.1* 0.2, 0.8 0.3 ± 0.07
Hunger vs PYY 0.3 ± 0.1* 0.5, 0.1 0.3 ± 0.07
Desire to Eat vs PYY 0.4 ± 0.3* 0.7, 0.2 0.3 ± 0.08
Satiety vs CCK 3.3 ± 6.3 11.6, 18.3 0.1 ± 0.03
Fullness vs CCK 2.8 ± 7.8 15.5, 21.2 0.1 ± 0.05
Hunger vs CCK 0.1 ± 5.3 12.6, 12.4 0.1 ± 0.02
Desire to Eat vs CCK 4.0 ± 6.9 20.5, 12.4 0.1 ± 0.03
Satiety vs Insulin 0.9 ± 0.2* 0.5, 1.2 0.4 ± 0.08
Fullness vs Insulin 0.9 ± 0.2* 0.5, 1.3 0.4 ± 0.08
Hunger vs Insulin 0.8 ± 0.2* 1.1, 0.4 0.4 ± 0.06
Desire to Eat vs Insulin 0.9 ± 0.2* 1.3, 0.5 0.5 ± 0.09
Satiety vs Glucose 7.0 ± 4.0 2.2, 16.1 0.3 ± 0.07
Fullness vs Glucose 7.7 ± 3.0* 0.8, 14.6 0.2 ± 0.05
Hunger vs Glucose 8.7 ± 2.1 13.6, 3.7 0.2 ± 0.07
Desire to Eat vs Glucose 9.0 ± 2.4* 14.5, 3.6 0.2 ± 0.07
PYY, Peptide YY; CCK, cholecystokinin. *Mean of the regression slopes signiﬁcantly
different from zero, P < 0.05 (Student's one sample t test).
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APPET2608_proof ■ 26 June 2015 ■ 7/8consumption in order to identify the mechanisms leading to the
adjustment of energy intake commonly seen after taking HENSD.
Primarily, we found that HENSD intake displaced some food sub-
sequently eaten and thus increased net energy intake by only half
the amount the energy supplied. The novel ﬁnding of this study is
that energy compensation following consumption of HENDS is
short lived and that intake of such supplement in the morning has
no impact on energy intake later during the day.
We found that the net cumulative effect on energy intake
(including supplement) was on average 1.07 MJ higher in the
HENSD compared to PLACEBO. Thus, taking into consideration that
predicted daily energy requirement of our participants consisted of
approximately 6.72, our ﬁndings suggest that supplementation
with HENSD applied to slightly undernourished healthy individuals
should not be expected to enhance energy intake above daily en-
ergy requirements by more than 17%. Our data also suggests that
overfeeding related to HENSD is not compromised by its effect on
resting metabolic rate (diet induced thermogenesis). Indeed, the
difference in energy expended above the metabolic rate during the
whole 240 min of the experimental trials consisted only of
approximately 0.124 MJ, whilst the net cumulative effect on energy
intake (including supplement) was an increase of approximately
1.07 MJ. In addition, relative increase in energy expenditure,
expressed as a percentage of the ingested energy, after the intake of
the supplement alone and combined intake of the supplement and
breakfast was relatively small and not signiﬁcantly different be-
tween the HENSD and PLACEBO trials.
Although analyses by two way ANOVA showed that all appetite
measures were not signiﬁcantly different between HENSD and
PLACEBO trials, comparison of summary responses of appetite
measures (calculated as AUCs) showed that during 60 min post-
supplementation, hunger suppression and enhancement in
satiety was more profound after the HENSD than PLACEBO intake.
This is in consistent with other studies reporting an effect of energy
content of preload on appetite responses (Karl, Young, Rood, &
Montain, 2013). Several mechanisms could have been responsible
for these differences. Enhanced satiety and reduced hunger
immediately after HENSD supplementation can be attributed to
signiﬁcantly higher plasma concentrations of PYY and CCK, which
are known to elicit anorexigenic effects (Chaudhri, Field, & Bloom,
2008; Suzuki, Simpson, Minnion, Shillito, & Bloom, 2010) and to
insulin, which plays a role in appetite regulation of lean individuals
(A. Flint et al., 2007). Since delayed gastric emptying has been
proposed to reduce hunger and enhance satiety by increasing
gastric volume and stretch (Wang et al., 2008), the more profound
appetite suppression found during immediate hour after supple-
mentation with HENSD could also be related to slower gastric
emptying. We found that concentration of plasma paracetamol, a
proxy measure of gastric emptying (N€aslund, 2000) was signiﬁ-
cantly lower after HENSD than PLACEBO intake.
Enhanced satiety and reduced hunger in HENSD trial, found
during 60 min post supplementation (pre-lunch period), coincided
with lower energy intake during ad libitum breakfast, but energy
provided by combined intake of the supplement and breakfast was
still signiﬁcantly higher in the HENSD than the PLACEBO trial.
Despite this overfeeding, subjective appetite measures during pre-
lunch period and energy intake during ad libitum lunch did not
differ between the HENSD and PLACEBO trials. Thus, HENSD may
improve energy and nutritional intake in individuals with an
increased risk of becoming malnourished (Cawood et al., 2012; R.J.
Stratton & Elia, 2010; Rebecca J. Stratton et al., 2013) as the sup-
pressive response of appetite and energy compensation following
consumption of such supplements is short lived.
Even though the enhanced satiety and reduced hunger
measured for 60 min (pre-breakfast period) after HENSDPlease cite this article in press as: Fatima, S., et al., Response of appetit
nutritional supplements, Appetite (2015), http://dx.doi.org/10.1016/j.appsupplementation coincided with signiﬁcantly higher plasma con-
centrations of PYY, CCK and insulin, during the pre-lunch period
there was dissociation between appetite measures and expected
action of hormonal appetite regulators, a phenomenon also found
in some other studies (De Graaf, Blom, Smeets, Staﬂeu, & Hendriks,
2004; Doucet et al., 2008; Gielkens, Verkijk, Lam, Lamers, &
Masclee, 1998). For further understanding of relations between
responses of appetite scores and hormone responses we used a
statistical approach that focuses on within participant relations
between changes in appetite scores and changes in hormone con-
centrations (Lemmens et al., 2011) and obtained regression slopes
and R2 values for the regression of appetite scores on each of the
measured appetite hormones. We found that within participant
relations between responses of appetite scores and responses of
hormones showed signiﬁcant correlations with regards to PYY and
insulin, but not CCK. Thus, our ﬁndings contribute to the debate
aboutwhether appetite hormones act as biomarkers of appetite (De
Graaf et al., 2004; A. Flint et al., 2007; Lemmens et al., 2011) and
support the notion of the subjective appetite measures being better
correlates of energy intake than circulating levels of individually
considered appetite hormones (Doucet et al., 2008).
Some studies (Crovetti et al., 1998; Mansour et al., 2012;
Westerterp-Plantenga et al.,1997) suggest that appetite and
satiety are inﬂuenced by an increase in energy expenditure in the
postprandial period due to absorbing, metabolizing, and storing
ingested nutrients (Tappy, 1996), a phenomenon known as diet
induced thermogenesis. Studies have found that higher diet
induced thermogenesis (DIT) is correlated with reduced hunger
and more satiety (Crovetti et al., 1998; Mansour et al., 2012;
Westerterp-Plantenga et al.,1997). Thus, the current study also
aimed to ﬁnd out whether appetite responses following HENSD
consumption were related to change in postprandial energy
expenditure. We found that during 60 min post-supplementation
energy expended above resting metabolic rate was signiﬁcantly
higher in the HENSD than PLACEBO trial, which coincided with
lower hunger and higher satiety. The increase in diet induced
thermogenesis persisted into the pre-lunch period, but this was not
reﬂected in satiety and appetite differences. Thus, our data shows
no consistent relationship between diet-induced thermogenesis
and appetite and satiety regulation, which is in line with the
ﬁndings from recent meta-analyses (Ravn et al., 2013). It has been
suggested that satiety might be related to diet induced thermo-
genesis only on a high protein diet (Veldhorst et al., 2008). Thus, the
protein content (11.9 g) of the HENSD supplement may be insufﬁ-
cient in terms of triggering a satiating effect through
thermogenesis.
The study design included the use of preload paradigmwhich is
an establishedmethodology to assess the effects of food or drink on
appetite and energy intake in the short term, under controlled
conditions (Almiron-Roig et al., 2013). This design overcomes
misreporting of food intake, allowing precise measurement of en-
ergy intake. To further optimize the quality of energy intake data,
foods included in breakfast and lunch and leftovers of breakfast and
lunchwereweighed and analysed by two researchers. In contrast to
most other studies, our study investigated the impact of HENSD
consumption on energy compensation during two consecutive
meals to explore shorter and longer term effect on food intake. This
allowed us to ﬁnd out that appetite suppressive responses and
energy compensation is acute only, disappearing quite quickly. It
should be noted however that the laboratory environment was
experimental, and thus energy intake may have deviated from
normal eating behaviours (Hetherington, Anderson, Norton, &
Newson, 2006).
This study has some limitations. We recruited slim, but healthy
young women in order to simulate the likely effect of HENSD ine and potential appetite regulators following intake of high energy
et.2015.06.010
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APPET2608_proof ■ 26 June 2015 ■ 8/8younger malnourished patients, since most previous research had
been done in the elderly. Thus, results obtained in this study are
more likely to be relevant to adolescents and younger adults, and
cannot necessarily be generalized to sick people at risk of malnu-
trition where various other disease-associated factors impact en-
ergy intake and regulation. The responses of metabolic and
hormonal appetite regulators were investigated in a subset of the
study participants, as power calculations suggested that investi-
gation of nine participants would allow identiﬁcation of physio-
logically meaningful and signiﬁcant differences in postprandial
PYY, CCK, glucose, insulin, concentrations. Only medium term
regulation of appetite and energy intake was measured which
might not be applicable to clinical or home settings where HENSD
are prescribed for long-term periods.
In summary, our study suggests that HENSD intake induces a
partial and relatively short lived suppressive action on appetite and
energy intake. In the short term these supplements increase net
energy intake by about half the energy value of the supplement
taken. This has an important implication if prescribing supple-
ments to malnourished individuals.
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